Lead Product(s) : Magnesium Glycinate
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Pure Encapsulations
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure
Details : Magnesium Glycinate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 19, 2023
Lead Product(s) : Magnesium Glycinate
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Pure Encapsulations
Deal Size : Inapplicable
Deal Type : Inapplicable